Brain Tumor Diagnostics and Therapeutics Market, Global Outlook and Forecast 2023-2029
Report Code: KNJ1494301 No. of Pages: 66 Category: Medical Devices
Publisher: Date of Publish:
Publisher: Date of Publish:
This report aims to provide a comprehensive presentation of the global market for Brain Tumor Diagnostics and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Tumor Diagnostics and Therapeutics. This report contains market size and forecasts of Brain Tumor Diagnostics and Therapeutics in global, including the following market information:
Global Brain Tumor Diagnostics and Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Brain Tumor Diagnostics and Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Surgery Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Brain Tumor Diagnostics and Therapeutics include Pfizer, Novartis, Roche, Merck, Curtana Pharmaceuticals, GE Healthcare, Hitachi Medical, Philips Healthcare and Novocure, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brain Tumor Diagnostics and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brain Tumor Diagnostics and Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Brain Tumor Diagnostics and Therapeutics Market Segment Percentages, by Type, 2022 (%)
Surgery
Radiation Therapy
Targeted Therapy
Chemotherapy
Others
Global Brain Tumor Diagnostics and Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Brain Tumor Diagnostics and Therapeutics Market Segment Percentages, by Application, 2022 (%)
Hospitals and Cancer Center
Oncology Treatment Centers
Others
Global Brain Tumor Diagnostics and Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Brain Tumor Diagnostics and Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Brain Tumor Diagnostics and Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Brain Tumor Diagnostics and Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Roche
Merck
Curtana Pharmaceuticals
GE Healthcare
Hitachi Medical
Philips Healthcare
Novocure
AbbVie
Daiichi Sankyo
Genetech
Carthera
EMulate Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Brain Tumor Diagnostics and Therapeutics, market overview.
Chapter 2: Global Brain Tumor Diagnostics and Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Brain Tumor Diagnostics and Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Brain Tumor Diagnostics and Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Brain Tumor Diagnostics and Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Brain Tumor Diagnostics and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Brain Tumor Diagnostics and Therapeutics Overall Market Size
2.1 Global Brain Tumor Diagnostics and Therapeutics Market Size: 2022 VS 2029
2.2 Global Brain Tumor Diagnostics and Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Brain Tumor Diagnostics and Therapeutics Players in Global Market
3.2 Top Global Brain Tumor Diagnostics and Therapeutics Companies Ranked by Revenue
3.3 Global Brain Tumor Diagnostics and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Brain Tumor Diagnostics and Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Brain Tumor Diagnostics and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Brain Tumor Diagnostics and Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Brain Tumor Diagnostics and Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Brain Tumor Diagnostics and Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Brain Tumor Diagnostics and Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Surgery
4.1.3 Radiation Therapy
4.1.4 Targeted Therapy
4.1.5 Chemotherapy
4.1.6 Others
4.2 By Type - Global Brain Tumor Diagnostics and Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Brain Tumor Diagnostics and Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Brain Tumor Diagnostics and Therapeutics Market Size, 2022 & 2029
5.1.2 Hospitals and Cancer Center
5.1.3 Oncology Treatment Centers
5.1.4 Others
5.2 By Application - Global Brain Tumor Diagnostics and Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Brain Tumor Diagnostics and Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Brain Tumor Diagnostics and Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Brain Tumor Diagnostics and Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Brain Tumor Diagnostics and Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2029
6.3.2 US Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.3.3 Canada Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.3.4 Mexico Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2029
6.4.2 Germany Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.4.3 France Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.4.4 U.K. Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.4.5 Italy Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.4.6 Russia Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.4.8 Benelux Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2029
6.5.2 China Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.5.3 Japan Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.5.4 South Korea Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.5.6 India Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2029
6.6.2 Brazil Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.6.3 Argentina Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2029
6.7.2 Turkey Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.7.3 Israel Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.7.5 UAE Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
7 Brain Tumor Diagnostics and Therapeutics Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.1.4 Pfizer Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.2.4 Novartis Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.3.4 Roche Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.4.4 Merck Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Curtana Pharmaceuticals
7.5.1 Curtana Pharmaceuticals Company Summary
7.5.2 Curtana Pharmaceuticals Business Overview
7.5.3 Curtana Pharmaceuticals Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.5.4 Curtana Pharmaceuticals Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Curtana Pharmaceuticals Key News & Latest Developments
7.6 GE Healthcare
7.6.1 GE Healthcare Company Summary
7.6.2 GE Healthcare Business Overview
7.6.3 GE Healthcare Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.6.4 GE Healthcare Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.6.5 GE Healthcare Key News & Latest Developments
7.7 Hitachi Medical
7.7.1 Hitachi Medical Company Summary
7.7.2 Hitachi Medical Business Overview
7.7.3 Hitachi Medical Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.7.4 Hitachi Medical Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Hitachi Medical Key News & Latest Developments
7.8 Philips Healthcare
7.8.1 Philips Healthcare Company Summary
7.8.2 Philips Healthcare Business Overview
7.8.3 Philips Healthcare Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.8.4 Philips Healthcare Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Philips Healthcare Key News & Latest Developments
7.9 Novocure
7.9.1 Novocure Company Summary
7.9.2 Novocure Business Overview
7.9.3 Novocure Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.9.4 Novocure Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Novocure Key News & Latest Developments
7.10 AbbVie
7.10.1 AbbVie Company Summary
7.10.2 AbbVie Business Overview
7.10.3 AbbVie Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.10.4 AbbVie Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.10.5 AbbVie Key News & Latest Developments
7.11 Daiichi Sankyo
7.11.1 Daiichi Sankyo Company Summary
7.11.2 Daiichi Sankyo Business Overview
7.11.3 Daiichi Sankyo Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.11.4 Daiichi Sankyo Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.11.5 Daiichi Sankyo Key News & Latest Developments
7.12 Genetech
7.12.1 Genetech Company Summary
7.12.2 Genetech Business Overview
7.12.3 Genetech Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.12.4 Genetech Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.12.5 Genetech Key News & Latest Developments
7.13 Carthera
7.13.1 Carthera Company Summary
7.13.2 Carthera Business Overview
7.13.3 Carthera Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.13.4 Carthera Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.13.5 Carthera Key News & Latest Developments
7.14 EMulate Therapeutics
7.14.1 EMulate Therapeutics Company Summary
7.14.2 EMulate Therapeutics Business Overview
7.14.3 EMulate Therapeutics Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.14.4 EMulate Therapeutics Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.14.5 EMulate Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com